Communiqués

Get a deeper look into the latest issues surrounding compliance regulations and learning solutions in your industry.

Showing results for 17 resources
  • Pharmaceutical Communiqué Q2 2016

    Pharmaceutical Communiqué Q2 2016

    Read up on FDA imports alerts and cGMP compliance, the challenge of change management for data integrity,the visual SOP quiz best practices, and reporting post-approval changes to FDA

  • Health Care Communiqué Q1 2016

    Health Care Communiqué Q1 2016

    This communiqué discusses the arrival of a new Gleevec generic, independent auditor validations, CMS Part D prescriber enrollment requirements, biosimilars, and the timeline for Q1 CMS due dates.

  • Health Care Communiqué Q1 2017

    Health Care Communiqué Q1 2017

    This communiqué discusses the The Future of Medicare Advantage Provider Directory Requirements, The 2016 Civil Monetary Penalties List, The First 2017 Audit Notices and more!

  • Health Care Communiqué Q2 2015

    Health Care Communiqué Q2 2015

    This communiqué covers 2015 CMS audit protocol highlights, UL perspectives on biosimilars, HPMS OMS updates, and 2015 Part C and D call center monitoring and guidance.

  • Health Care Communiqué Q3 2015

    Health Care Communiqué Q3 2015

    This communiqué covers two CMS pilot audit programs, specialty drugs classifications, a prescriber validation update, a synopsis of the 2015 MMP call center study, and the latest fraud update from UL.

  • Health Care Communiqué Q4 2015

    Health Care Communiqué Q4 2015

    Read up on CMS Part D prescriber enrollment requirements, CMS program audit updates for 2015 and 2016, MTM 2016 star cut-points, an overview of Addyi (flibanserin), and the CMS timeline.

  • Health Care Communiqué Year-End 2015

    Health Care Communiqué Year-End 2015

    This document reviews new government standards for accountability at the individual officer level, how anti-corruption laws apply to donations made to China and the risk of procurement fraud within the supply chain.

  • Health Care Compliance Communiqué Q1 2015

    Health Care Compliance Communiqué Q1 2015

    This communiqué explores considerations for anti-corruption programs, compliance implications of recent changes in anti-corruption laws and enforcement, and how to combat training fatigue over time.

  • Health Care Compliance Communiqué Q1 2016

    Health Care Compliance Communiqué Q1 2016

    This communiqué covers FCPA lessons from 2015, Life Sciences data theft and HIPAA, and DOJ expansion of FCPA resources.